Cargando…
Phenylacetylglutamine, a Novel Biomarker in Acute Ischemic Stroke
Background: To discover novel metabolic biomarkers of ischemic stroke (IS), we carried out a two-stage metabolomic profiling of IS patients and healthy controls using untargeted and targeted metabolomic approaches. Methods: We applied untargeted liquid chromatography-mass spectrometry (LC-MS) to det...
Autores principales: | Yu, Fang, Li, Xi, Feng, Xianjing, Wei, Minping, Luo, Yunfang, Zhao, Tingting, Xiao, Bo, Xia, Jian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8733610/ https://www.ncbi.nlm.nih.gov/pubmed/35004911 http://dx.doi.org/10.3389/fcvm.2021.798765 |
Ejemplares similares
-
Gut-Derived Metabolite Phenylacetylglutamine and White Matter Hyperintensities in Patients With Acute Ischemic Stroke
por: Yu, Fang, et al.
Publicado: (2021) -
Association of Plasma Metabolic Biomarker Sphingosine-1-Phosphate With Cerebral Collateral Circulation in Acute Ischemic Stroke
por: Yu, Fang, et al.
Publicado: (2021) -
Neutrophil-to-Lymphocyte Ratio as a Predictive Biomarker for Stroke Severity and Short-Term Prognosis in Acute Ischemic Stroke With Intracranial Atherosclerotic Stenosis
por: Ying, Yuanlin, et al.
Publicado: (2021) -
Dysbiosis of Gut Microbiota and Metabolite Phenylacetylglutamine in Coronary Artery Disease Patients With Stent Stenosis
por: Fang, Chen, et al.
Publicado: (2022) -
Alteration of the gut microbiota and metabolite phenylacetylglutamine in patients with severe chronic heart failure
por: Zhang, Zhendong, et al.
Publicado: (2023)